Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y019173 | OT |
No symptoms reported; HCP reported 14 year old patient receiving PROQUAD inadvertently; This spontaneous report was received from a physician assistant and refers to a 14-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-Jun-2025, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), solution for injection (lot #Y019173, expiration date: 18-May-2026), the vaccine was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot# 1973239, expiration date: 14-Feb-2026), dose at 0.5 mL, administered as prophylaxis (route of administration, anatomical site and dose number in series were not provided) (Product administered to patient of inappropriate age). No symptoms reported (No adverse event). In addition, it was stated that they planned to complete a Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine (M-M-R II) series for this patient.
Sterile diluent